Pretargeted Radioimmunotherapy for Hematologic and Other Malignancies-Reference-Cited by-同舟云学术

Pretargeted Radioimmunotherapy for Hematologic and Other Malignancies

Published:2010-04 Issue:2 Volume:25 Page:125-142
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Walter Roland B.¹²,Press Oliver W.¹³,Pagel John M.¹³

Affiliation:

1. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.

2. Division of Hematology, Department of Medicine, University of Washington, Seattle, Washington.

3. Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.2010.0759

Reference163 articles.

1. Radioimmunotherapy for treatment of B-cell lymphomas and other hematologic malignancies

2. Update:Systemic Radiotherapy Can Cure Lymphoma: A Paradigm for Other Malignancies?

3. Pretargeted Radioimmunotherapy for B-Cell Lymphomas

4. Pharmacokinetic modeling

5. Radiohalogens for Radioimmunotherapy

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DTPA(DOTA)-Nimotuzumab Radiolabeling with Generator-produced Thorium for Radioimmunotherapy of EGFR-overexpressing Carcinomas;Current Radiopharmaceuticals;2023-09

2. Antibody-based Radiopharmaceuticals as Theranostic Agents: An Overview;Current Medicinal Chemistry;2022-11

3. Theranostics of Hematologic Disorders;Nuclear Medicine and Immunology;2021-11-25

4. Radioimmunotherapy;Nuclear Medicine and Immunology;2021-11-25

5. Genetic Alterations in Gliomas Remodel the Tumor Immune Microenvironment and Impact Immune-Mediated Therapies;Frontiers in Oncology;2021-06-08